China Universal Asset Management Company’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.16K | Buy |
2,576
+38
| +1% | +$91 | ﹤0.01% | 472 |
|
|
2025
Q1 | $10.9K | Sell |
2,538
-145
| -5% | -$623 | ﹤0.01% | 476 |
|
|
2024
Q4 | $23.1K | Buy |
2,683
+2,040
| +317% | +$17.5K | ﹤0.01% | 481 |
|
|
2024
Q3 | $10.9K | Buy |
643
+250
| +64% | +$4.25K | ﹤0.01% | 415 |
|
|
2024
Q2 | $5.93K | Sell |
393
-246
| -38% | -$3.71K | ﹤0.01% | 406 |
|
|
2024
Q1 | $10.6K | Buy |
639
+253
| +66% | +$4.2K | ﹤0.01% | 432 |
|
|
2023
Q4 | $6.17K | Buy |
+386
| New | +$6.17K | ﹤0.01% | 417 |
|